FDA Drug · D-0840-2026

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).

Class III · Ongoing

Labeling: Label Mix-up

Affected lots / codes — check yours against thisLot # 1030023, Exp Date: 06/30/2027.

Recalling firm: American Health Packaging, Columbus, OH
Classification: Class III (unlikely to cause harm)
Status: Ongoing
Quantity: 10,953 cartons.
Distribution: US Nationwide.
Recall initiated: August 19, 2026
Classified: September 14, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0840-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →